Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Infasurf Market Expansion From $ Billion In 2026 To $ Billion In 2030
The historical expansion was driven largely by the frequent occurrence of neonatal respiratory distress syndrome, along with the well-documented effectiveness of surfactant replacement treatments. This growth also benefited from the broader availability and development of neonatal intensive care units, which improved outcomes for premature infants. Additionally, the rising survival rates among preterm babies and the widespread integration of surfactant therapy into hospital protocols further supported this upward trend.
The increase projected for the forecast period is driven by a higher number of preterm births worldwide, greater investment in neonatal healthcare services, enhanced availability of NICU care, progress in surfactant product development, and an expansion of neonatal care facilities. Key developments shaping the forecast period involve a growing adoption of natural lung surfactants, an uptick in preterm birth statistics, better protocols for neonatal intensive care, prompt management of respiratory distress, and the establishment of standardized surfactant treatment for newborns.
Download A Free Sample Report For Comprehensive Market Insights:
Infasurf Market Opportunity Drivers: What Is Creating New Revenue Potential?
The anticipated expansion of the infasurf market in the coming years is expected to be propelled by the growing frequency of premature births. A premature birth, often referred to as a preterm delivery, occurs when a baby is born prior to completing 37 weeks of gestation, differing from a full-term birth that normally takes place at around 40 weeks; this condition frequently leads to several health challenges for the infant, such as breathing difficulties, developmental delays, and a heightened likelihood of enduring long-term impairments. Various elements contribute to the escalating rate of premature births, including an increase in maternal age, a higher occurrence of multiple pregnancies resulting from assisted reproductive technologies, and the effects of chronic medical conditions and infections experienced during pregnancy. Infasurf, also known as calfactant, is delivered straight into the lungs of preterm infants to either prevent or manage respiratory distress syndrome (RDS) by lowering surface tension and boosting lung performance. As an example, a report issued in October 2024 by the University of Bristol, a public research institution located in the UK, indicated that roughly one out of every 13 births is preterm, amounting to more than 50,000 instances each year. Even though preventive strategies are available for women at elevated risk, preterm birth rates are still climbing. Consequently, the rising occurrence of premature births is fueling the expansion of the infasurf market.
The expansion of the infasurf market is expected to be driven forward by increasing healthcare spending. Healthcare spending encompasses the total financial resources assigned by individuals, governments, private insurers, and other organizations toward the provision of healthcare-related services and products. This upward trend in healthcare expenditure results from an aging population, progress in medical technology, a growing frequency of chronic illnesses, and an elevated need for healthcare services. By lessening the economic strain caused by extended hospital stays and complex respiratory treatments for preterm infants facing respiratory distress syndrome, infasurf plays a beneficial role in healthcare spending, ultimately improving cost efficiency in neonatal care. For instance, data from the Office for National Statistics, a UK governmental department, published in May 2024, shows that healthcare spending in the UK rose by 5.6% between 2022 and 2023, in contrast to a 0.9% growth in 2022. In 2023, the UK’s healthcare expenditure reached approximately $317.63 billion (£292 billion). Thus, the increase in healthcare expenditure is fostering the growth of the infasurf market.
The infasurf market is expected to be driven forward by growing awareness of infant respiratory disorders. Infant respiratory disorders describe a variety of conditions that impact the breathing and lung functionality of newborns, frequently arising from underdeveloped lungs or complications encountered during birth. An uptick in the prevalence of these disorders is fueled by increasing rates of preterm births, maternal health issues, environmental influences, higher frequencies of cesarean deliveries, and better detection and diagnosis made possible through advanced medical technologies. As a surfactant replacement therapy, infasurf aids in treating infant respiratory conditions by enhancing lung function and oxygenation in preterm infants with respiratory distress syndrome, reducing lung surface tension, and improving their capacity to expand and exchange gases effectively. For example, according to a September 2024 report from the Centers for Disease Control and Prevention, a U.S. government agency, an estimated 58,000 to 80,000 children under the age of 5 are hospitalized annually in the United States due to RSV infection, with infants facing the highest risk. Hence, the increasing awareness of infant respiratory disorders is propelling the growth of the infasurf market.
Infasurf Market Segments: Where Are The Largest Growth Opportunities?
The infasurf market covered in this report is segmented –
1) By Patient Demographics: Premature Infants, Full-Term Infants, Age Groups
2) By Distribution Channel: Hospitals, Specialty Clinics, Online Pharmacies, Pharmacies
3) By Application: Neonatal Respiratory Distress Syndrome, Other Respiratory Conditions
Infasurf Market Major Participants And Competitive Dynamics
Major companies operating in the infasurf market are ONY Biotech Inc.
Access The Complete Infasurf Market Report:
Infasurf Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the infasurf market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infasurf market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model